Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | kinase insert domain receptor | Starlite/ChEMBL | References |
Homo sapiens | TEK tyrosine kinase, endothelial | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Onchocerca volvulus | Get druggable targets OG5_130320 | All targets in OG5_130320 | |
Onchocerca volvulus | Tyrosine kinase homolog | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Brugia malayi | Immunoglobulin I-set domain containing protein | Get druggable targets OG5_130320 | All targets in OG5_130320 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | neuroglian | 0.0014 | 0.0187 | 0.0354 |
Echinococcus granulosus | roundabout 2 | 0.0022 | 0.065 | 0.1232 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0272 | 0.0272 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0021 | 0.0021 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0272 | 0.0272 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0102 | 0.5273 | 0.5 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0102 | 0.5273 | 0.5 |
Brugia malayi | eukaryotic initiation factor 4A | 0.0102 | 0.5273 | 0.5273 |
Echinococcus granulosus | neuroglian | 0.0014 | 0.0187 | 0.0354 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0102 | 0.5273 | 1 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0102 | 0.5273 | 0.5 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0016 | 0.0272 | 0.0272 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0011 | 0.0021 | 0.004 |
Onchocerca volvulus | 0.0167 | 0.9006 | 0.9259 | |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0102 | 0.5273 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0399 | 0.0399 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0184 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0021 | 0.0021 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.5273 | 0.5273 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0102 | 0.5273 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0272 | 0.0272 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0011 | 0.0021 | 0.004 |
Onchocerca volvulus | Tyrosine kinase homolog | 0.0172 | 0.9305 | 1 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0102 | 0.5273 | 1 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0102 | 0.5273 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0021 | 0.0021 |
Echinococcus granulosus | Immunoglobulin | 0.0011 | 0.0021 | 0.004 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0102 | 0.5273 | 1 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0016 | 0.0272 | 0.0272 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0102 | 0.5273 | 0.5 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0102 | 0.5273 | 1 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0102 | 0.5273 | 0.5 |
Echinococcus granulosus | twitchin | 0.0014 | 0.0187 | 0.0354 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0015 | 0.0233 | 0.0441 |
Echinococcus multilocularis | roundabout 2 | 0.0022 | 0.065 | 0.1232 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0233 | 0.0233 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0102 | 0.5273 | 0.5 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0272 | 0.0272 |
Schistosoma mansoni | cell adhesion molecule | 0.0019 | 0.0484 | 0.0917 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0399 | 0.0399 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0021 | 0.004 |
Echinococcus multilocularis | Immunoglobulin | 0.0011 | 0.0021 | 0.004 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0102 | 0.5273 | 0.5 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0102 | 0.5273 | 0.5 |
Plasmodium vivax | RNA helicase-1, putative | 0.0102 | 0.5273 | 0.5 |
Echinococcus granulosus | defective proboscis extension response | 0.0011 | 0.0021 | 0.004 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0102 | 0.5273 | 0.5 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0102 | 0.5273 | 0.5 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0011 | 0.0021 | 0.004 |
Schistosoma mansoni | vesicular amine transporter | 0.0011 | 0.0021 | 0.004 |
Schistosoma mansoni | nephrin | 0.0018 | 0.0438 | 0.083 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0102 | 0.5273 | 0.5 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0102 | 0.5273 | 0.5 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0102 | 0.5273 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA | ChEMBL. | 17676829 | |
IC50 (binding) | 0 | Inhibition of TIE-2/c-fms chimeric protein expressed in mouse 3T3 cells assessed as autophosphorylation level by ELISA | ChEMBL. | 17676829 |
IC50 (binding) | = 3200 nM | Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus | ChEMBL. | 17676829 |
IC50 (binding) | = 3200 nM | Inhibition of GST-tagged human recombinant TIE2 expressed in baculovirus | ChEMBL. | 17676829 |
IC50 (binding) | = 4000 nM | Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus | ChEMBL. | 17676829 |
IC50 (binding) | = 4000 nM | Inhibition of GST-tagged human recombinant VEGFR2 expressed in baculovirus | ChEMBL. | 17676829 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.